Key Highlights
- Phosphofructokinase (PFK Enzyme) shows a dual role beyond glycolysis
- The Pfk2 subunit binds and unwinds mRNA, influencing protein synthesis
- Direct link identified between cellular metabolism and cell cycle progression
- Findings may reshape understanding of cell proliferation and disease pathways
How Does the PFK Enzyme Regulate Cell Division Beyond Metabolism?
A new study led by the University of Surrey reveals that the well-known metabolic enzyme phosphofructokinase (PFK) plays a second, unexpected role in regulating cell division. Traditionally recognized as a key regulator of glycolysis, PFK has now been shown to influence cell cycle progression through RNA interaction.
In Saccharomyces cerevisiae, the PFK Enzyme consists of two subunits, Pfk1 and Pfk2. While both contribute to energy metabolism, researchers discovered that Pfk2 functions independently as an RNA-binding protein, interacting with more than 800 messenger RNAs (mRNAs). Notably, Pfk2 can unwind double-stranded RNA, a property typically associated with RNA helicases.
What Happens When Pfk2 Function Is Disrupted?
Experimental findings demonstrated that yeast cells lacking Pfk2 exhibited delayed growth, increased cell size, and impaired transition from G1 to S phase—a critical checkpoint in cell division.
Further analysis using polysome profiling revealed reduced translation of key regulatory proteins, such as:
- CLN3 (G1 cyclin initiating cell division)
- BUB3 (spindle checkpoint regulator)
Importantly, restoring a glycolysis-deficient version of Pfk2 reversed these defects. This confirms that Pfk2’s role in cell cycle regulation is independent of its metabolic function.
A Molecular Relay Between Energy Status and Cell Proliferation
The study proposes a “molecular relay switch” model:
- Under low-energy conditions, the PFK enzyme prioritizes glycolysis
- Under high energy availability, Pfk2 shifts to an RNA-regulatory role, promoting translation of cell cycle genes
This dual functionality establishes a direct mechanistic link between metabolism and cell proliferation, offering new insights into diseases characterized by dysregulated cell growth, including cancer.
For healthcare professionals and researchers, these findings highlight a critical paradigm shift: metabolic enzymes may have hidden regulatory roles impacting gene expression and cell division.
Why This Matters for Clinical Research and Therapeutics
Understanding the dual role of PFK could influence future research in:
- Cancer biology and tumor progression
- Targeted therapies regulating cell cycle control
- Metabolic disorders with proliferative components
Explore All Molecular Biology CME Conferences & Online Courses 2026
This discovery opens the door to exploring non-canonical functions of enzymes, potentially identifying new therapeutic targets in oncology and molecular medicine.
Source:
more recommended stories
Cannabis and Tobacco Co-Use May Increase Psychosis RiskKey Takeaways A new study in.
Walking 8,500 Steps May Prevent Weight RegainKey Points A new meta-analysis presented.
Hantavirus Cruise Ship Outbreak: WHO Issues UpdateKey Points WHO confirmed a cluster.
Autoimmune Diseases in Women Linked to Gene RegulationKey Points Researchers identified more than.
Skin Cancer Risk After Transplant Needs Better ScreeningKey Points Summary Solid organ transplant.
Polygenic Risk Scores Improve Early Heart Disease DetectionKey Points A new multicondition polygenic.
Prenatal Sedatives Psychiatric Risk: New Study FindingsQuick Summary A large South Korean.
Cardiovascular Health from Early Life Lowers Disease RiskKey Points Summary: Cumulative cardiovascular health.
Early Autism Detection Using Wearable Sensors in InfantsKey Highlights: Wearable movement sensors may.
Alzheimer’s Disease Driven by Cancer Gene MutationsKey Highlights Microglial cells in Alzheimer’s.

Leave a Comment